|
Early vs no recurrence in combined therapy group
|
---|
|
Univariate analysis
|
p Value
|
Multivariate analysis
|
p Value
|
---|
ALDH1, ≤1 %/>1 %
|
4.054 (1.797–10.080)
|
<0.001
|
4.625 (1.881–12.474)
|
<0.001
|
Age, ≤50/>50 years
|
0.612 (0.349–1.067)
|
0.083
|
0.623 (0.330–1.164)
|
0.138
|
Tumor size, ≤20/>20 mm
|
2.553 (1.336–5.036)
|
0.004
|
2.130 (1.018–4.601)
|
0.044
|
Nodal metastasis negative/positive
|
4.357 (2.430–7.979)
|
<0.001
|
3.856 (2.026–7.519)
|
<0.001
|
Progesterone receptor staining, <20 %/≥20 %
|
1.035 (0.593–1.807)
|
0.903
|
Not selected
| |
Ki-67 staining, <20 %/≥20 %
|
1.592 (0.858–2.983)
|
0.140
|
0.791 (0.377–1.634)
|
0.529
|
Tumor grade 1 or 2/3
|
2.625 (1.285–5.595)
|
0.007
|
2.098 (0.940–4.848)
|
0.070
|
-
ALDH1 aldehyde dehydrogenase 1